Elanco Animal Health (ELAN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting called to order at 8:00 A.M. ET on May 21, 2026, with board members, executive committee, and auditors present.
Shareholders attended virtually, and the meeting was officially recorded.
Broadridge Financial Solutions appointed as Inspector of Election; record date set as March 26, 2026.
Financial performance review
2025 saw continued growth, exceeding expectations in revenue, adjusted EBITDA, and adjusted EPS.
First quarter 2026 outperformed, prompting raised guidance for the year.
Pet health business achieved 7% organic growth; farm animal business delivered 8% organic growth in 2025.
Innovation platform contributed $1.2 billion in revenue as of May 2026.
Board and executive committee updates
Board-nominated directors presented for election to one-year terms.
Board and executive committee expressed confidence in current strategy and leadership.
Latest events from Elanco Animal Health
- Q2 2026 saw double-digit revenue growth, margin expansion, and raised full-year guidance.ELAN
Q2 2026 - Innovation and operational efficiency drive growth and margin expansion across pet and farm segments.ELAN
Piper Sandler 37th Annual Healthcare Conference - Innovation pipeline and global reach drive strong growth and raised financial targets.ELAN
46th Annual William Blair Growth Stock Conference - Innovation and resilient pricing drive strong growth in animal health and farm segments.ELAN
Stifel Jaws & Paws Conference 2026 - Innovation and global reach drive strong growth and margin stability in animal health.ELAN
Investor presentation - Q1 2026 revenue up 15% to $1.371B, with raised guidance and strong innovation momentum.ELAN
Q1 2026 - Q1 2025 saw 4% organic growth, raised guidance, and accelerated debt paydown on strong innovation.ELAN
Q1 2025 - Blockbuster launches and innovation pipeline drive strong growth and sustainability in 2025.ELAN
43rd Annual J.P. Morgan Healthcare Conference 2025 - 2024 saw organic growth, margin gains, and debt reduction; 2025 targets innovation-led expansion.ELAN
Q4 2024